Orthofix Medical/$OFIX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Orthofix Medical
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Ticker
$OFIX
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,616
ISIN
US68752M1080
Website
Orthofix Medical Metrics
BasicAdvanced
$433M
-
-$3.72
0.88
-
Price and volume
Market cap
$433M
Beta
0.88
52-week high
$20.48
52-week low
$10.24
Average daily volume
475K
Financial strength
Current ratio
2.708
Quick ratio
1.317
Long term debt to equity
40.975
Total debt to equity
42.06
Interest coverage (TTM)
-2.34%
Profitability
EBITDA (TTM)
26.114
Gross margin (TTM)
68.67%
Net profit margin (TTM)
-17.78%
Operating margin (TTM)
-8.60%
Effective tax rate (TTM)
-1.58%
Revenue per employee (TTM)
$500,000
Management effectiveness
Return on assets (TTM)
-5.00%
Return on equity (TTM)
-27.82%
Valuation
Price to revenue (TTM)
0.528
Price to book
0.94
Price to tangible book (TTM)
2.37
Price to free cash flow (TTM)
-88.521
Free cash flow yield (TTM)
-1.13%
Free cash flow per share (TTM)
-12.47%
Growth
Revenue change (TTM)
5.85%
Earnings per share change (TTM)
9.40%
3-year revenue growth (CAGR)
20.02%
10-year revenue growth (CAGR)
7.45%
3-year earnings per share growth (CAGR)
25.70%
10-year earnings per share growth (CAGR)
16.97%
What the Analysts think about Orthofix Medical
Analyst ratings (Buy, Hold, Sell) for Orthofix Medical stock.
Bulls say / Bears say
Orthofix Medical's U.S. Spine Fixation and Orthopedics segments demonstrated robust growth, with net sales increases of 16% and 23% respectively in Q1 2024, indicating strong market demand for their products. (finance.yahoo.com)
The company raised its full-year 2024 net sales guidance to between $790 million and $795 million, reflecting anticipated growth of 6% to 7% year-over-year, suggesting confidence in sustained revenue expansion. (finance.yahoo.com)
Orthofix's investments in enabling technologies and innovative products, such as the 7D FLASH system, are set to enhance market penetration and competitive advantage, potentially driving future revenue growth. (simplywall.st)
Orthofix Medical reported a net loss of $36 million in Q1 2024, significantly higher than the estimated net loss of $9.73 million, raising concerns about the company's profitability. (finance.yahoo.com)
The company's stock price has declined by 19.33% over the past year, indicating potential investor concerns about its financial performance and future prospects. (simplywall.st)
Orthofix Medical's earnings per share (EPS) for Q4 2023 were reported at -$0.59, missing analyst estimates of -$0.08, which may reflect operational challenges. (investorplace.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
Orthofix Medical Financial Performance
Revenues and expenses
Orthofix Medical Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Orthofix Medical stock?
Orthofix Medical (OFIX) has a market cap of $433M as of June 27, 2025.
What is the P/E ratio for Orthofix Medical stock?
The price to earnings (P/E) ratio for Orthofix Medical (OFIX) stock is 0 as of June 27, 2025.
Does Orthofix Medical stock pay dividends?
No, Orthofix Medical (OFIX) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Orthofix Medical dividend payment date?
Orthofix Medical (OFIX) stock does not pay dividends to its shareholders.
What is the beta indicator for Orthofix Medical?
Orthofix Medical (OFIX) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.